Gene Therapy
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Unlock global gene therapy market insights. Stay ahead on regulatory approvals, clinical trials, and investment opportunities in this cutting-edge biotech sector.
Showing 1–12 of 35 articles
Quick answer
NovaPharmaNews Gene Therapy hub for FDA covers 35 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Sensorion pivots to SENS-601 after Regeneron’s OTOF hearing loss advance
$2M Gene Therapy Cures Need a Financing Model
ASGCT Annual Meeting 2026: Live Event Coverage and Key Insights
FDA seeks to cut repeat work for gene therapy developers
Tenaya Therapeutics to Present TN-201 Gene Therapy Data for HCM on June 3, 2026
FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety
Eli Lilly's New Gene Therapy and Strategic Deals: Insights for Investors
Fetal Gene Therapy: Breaking the Taboo on Embryo Editing
23andMe Connects DNA Data with Medical Records: Implications for Pharma
India's Pharma Industry Goes Global: Can It Compete with China?
Fierce Biotech Week: Key Takeaways and Emerging Trends
ASGCT: Key Manufacturing Innovations Day 1
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.